2021-01-05,b'$NEU NEUREN PHARMACEUTICALS LIMITED https://t.co/jpbFinmQju'
2021-01-05,"b'I also see a big year ahead for $NEU.\n\nUltra impressive podcast by the CEO recently. As one of the best judges of Bios in AUS said to me ,there are no red flags for $NEU in 2021.\n\nCould really surprise to the upside.'"
2021-01-04,"b""Rose Above Previous Day's High today: $VIACA $NEU $MYY $EOD $PBE $PFO $FMX $VBLT $VOC $GHC $DLNG $EVM $AUTL $HTGM $XSHD $FGB $PKOH $DBLV $KOCT $NURO ... https://t.co/TBYRpvrFqi"""
2021-01-04,b'RT @MorgansHealthc1: PODCAST: Healthcare analysts Iain Wilkie and Scott Power wrap up with a year in review and call out a few top tips for\xe2\x80\xa6'
2021-01-03,b'@AgreonBrian $NEU - (a) shakeout (b) big rally (sign of strength) (c) supply absorption (d) volatility tightens (e) neat volume profile. Below $1.20 reassess #asx https://t.co/isdLeFWp6u'
2021-01-02,b'Stocks to watch Jan. 4 thru Jan. 8 $tfx $hum $gww $djco $neu $hubs $tdy $mstr $cwh $biol &amp; $TURN 180\xc2\xb0 Capital Corp. the catalyst https://t.co/MbzO6bgqGF stock tip $TURN'
2020-12-30,"b'@SottoDimitrios $IBX accidently exited $RHY recently on a stop loss and day of not watching so coming back in ASAP; did well on msb sold most near peak, holding some  $PXS $VHT $ANP $ATH $MDR $NEU had $ATX back in sept bought in too high but sold at peak and not re bought yet.'"
2020-12-30,b'Scan results - Shooting Star Candlestick today: $IMD $NEU $BKI $NCK $WHF $WGB $DTL $PMC ... https://t.co/y7eqrIjNsO'
2020-12-28,"b""Rose Above Previous Day's High today: $GLRE $UHAL $DRIP $DSGX $BBBY $FSP $VRAY $LSLT $ETO $NTG $NEU $VSMV $FARO $DWFI $NPK $GIM $COHR $EEMS $ARCO $FCOM ... https://t.co/TBYRpvrFqi"""
2021-01-09,b'RT @blueballs888: $neu 1.70 next https://t.co/3vcwOpRvpx'
2021-01-09,b'$neu 1.70 next https://t.co/3vcwOpRvpx'
2021-01-09,b'RT @Investie1: $NEU . Slowly moving up as we move towards Phase 1 NNZ-2591 results for 3 indications. With a lot of news in 2021 culminatin\xe2\x80\xa6'
2021-01-09,"b'$NEU . Slowly moving up as we move towards Phase 1 NNZ-2591 results for 3 indications. With a lot of news in 2021 culminating in the Acadia Pharma Trofinetide Phase 3 study in H2 2021, I expect we are at least heading back to old highs ($3.40+ range).'"
2021-01-08,b'$NEU NewMarket Corporation Schedules Conference Call and Webcast to Review Fourth Quarter 2020 and Full Year Financial Results https://t.co/kTMyAtjTc7'
2021-01-08,b'Conversations with Jags - Jan 8\n\n$TDOC fed opportunity to cover 8M lives remains big. $CIEN mgmt notes show continued biz improvement. $GNRC able to quantity nursing home opportunity. Cutting $NEU short. Reiterating bull case for $MTH and $ONEM long.\n\nhttps://t.co/i0eIV0Ydhv'
